Cell-Free Fetal DNA Testing Market to Reach US$ 3.5 Bn by 2033 | Persistence Market Research

AI Briefing

• – The cell-free fetal DNA testing market is expected to reach US$ 3.5 Bn by 2033, driven by rising maternal age, advanced screening accuracy, expanding access, and innovations in prenatal diagnostics.
• – Key players in the market are investing in R&D to improve the accuracy and efficiency of cell-free fetal DNA testing, with a focus on reducing costs and increasing accessibility.
• – Innovations such as non-invasive prenatal testing (NIPT) and maternal serum screening are expected to drive growth in the market, with a projected CAGR of 10.5% from 2023 to 2033.